Africa: Young, Black Woman Scientist Discovered Pivotal Leprosy Treatment in 1920s But Someone Took the Credit
[The Conversation Africa] Hansen's disease, also called leprosy, is treatable today - and that's partly thanks to a curious tree and the work of a pioneering young scientist in the 1920s. Centuries prior to her discovery, sufferers had no remedy for leprosy's debilitating symptoms or its social stigma. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 16, 2024 Category: African Health Tags: Africa External Relations Health and Medicine Science and Biotechnology United States, Canada and Africa Women and Gender Source Type: news
New surgical tower at TGH will bear a familiar name in Tampa health care circles
Tampa General Hospital said it has raised $120 million toward the construction of the 13-story tower. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 16, 2024 Category: Biotechnology Authors: Ashley Gurbal Kritzer Source Type: news
Kirkland company that treats panic attacks raises $22.6M, filing shows
The funding follows a $10 million round the health tech company raised in 2020. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 15, 2024 Category: Biotechnology Authors: Rick Morgan Source Type: news
Hines' new Levit Green life sciences campus near Texas Medical Center adds tenant
The building into which PranaX is moving is the first of nine planned on the Levit Green campus, which will offer a mix of research and biomanufacturing facilities, office, retail, residential and outdoor amenities. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 15, 2024 Category: Biotechnology Authors: Jeff Jeffrey Source Type: news
Fountain Hills medical device firm unveils FDA-approved OTC bioelectric bandage
On April 16, a Fountain Hills medical device company will unveil the first FDA-approved bioelectric bandage available over the counter directly to patients. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 15, 2024 Category: Biotechnology Authors: Angela Gonzales Source Type: news
America hits Chinese biotech
AMERICAN HEALTH-CARE costs are sky-high; as treatments get pricier and the number of patients swells owing to an ageing population, they are getting higher. Chinese biotechnology is increasingly sophisticated and, as its companies gain scale, getting cheaper. A growing number of American…#americanhealthcare #wuxiapptec #wuxibiologics #mgitech #wuxi #biosecureact #ip #pla #uyghurs #democrats (Source: Reuters: Health)
Source: Reuters: Health - April 15, 2024 Category: Consumer Health News Source Type: news
How big is the GLP-1 market? Exploring its growth potential By
GLP-1 receptor agonists are changing the way chronic conditions like type 2 diabetes are managed, but they have also been approved in the United States to treat obesity, resulting in investors assessing the various outcomes if they become more widely adopted. But how big is the market for these…#glp1 #goldmansachs #fatimacodystanford #glp1s #mit #jonathangruber #novonordiskas #medicare #goldman #biotech (Source: Reuters: Health)
Source: Reuters: Health - April 15, 2024 Category: Consumer Health News Source Type: news
ChrysCap buys small stake in generics company La Renon for Rs 600 cr
Incorporated in 2007 by Pankaj Singh, La Renon is engaged in the manufacturing and marketing of branded generic formulations. ChrysCapital is close to acquiring a minority stake in La Renon Healthcare via secondary sale of shares, at a valuation of Rs 6,500 crore ($800 million), ET first reported on February 12. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 15, 2024 Category: Pharmaceuticals Source Type: news
FDA pauses Watertown biotech ’s schizophrenia trial
The U.S. Food and Drug Administration placed a clinical hold on a Watertown biotech ’s schizophrenia drug trial after new pre-clinical data showed convulsions in rabbits. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 15, 2024 Category: Pharmaceuticals Authors: Hannah Green Source Type: news
Kristen Helton wants to rethink how health care for women 65+ is delivered
Kristen Helton is no stranger to the health care industry, having founded biosensor company Profusa, before going on to work at Amazon, where she helped lead the company ’s Amazon Care division.
But her latest mission is focused on advancing understanding around health disparities women 65 and older face, while providing a meaningful solution.
“The one thing I hear over and over from women is that they just don’t feel heard,” said the founder of St. Paul, Minnesota-based Herself Health.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 15, 2024 Category: Biotechnology Authors: Cindy Barth Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche ’s Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in Phase III STARGLO study
Columvi, in combination with chemotherapy, demonstrated a statistically significant improvement in overall survival for people with relapsed or refractory diffuse large B-cell lymphomaData from the STARGLO study will be submitted to health authorities and presented at an upcoming medical meetingBasel, 15 April 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the Phase III STARGLO study met its primary endpoint of overall survival. The study demonstrated that people with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), who have received at least one prior line of therapy and are not candidates fo...
Source: Roche Investor Update - April 15, 2024 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche ’s Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in Phase III STARGLO study
Columvi, in combination with chemotherapy, demonstrated a statistically significant improvement in overall survival for people with relapsed or refractory diffuse large B-cell lymphomaData from the STARGLO study will be submitted to health authorities and presented at an upcoming medical meetingBasel, 15 April 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the Phase III STARGLO study met its primary endpoint of overall survival. The study demonstrated that people with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), who have received at least one prior line of therapy and are not candidates fo...
Source: Roche Media News - April 15, 2024 Category: Pharmaceuticals Source Type: news
Peoria doctor pleads guilty in health care fraud case
Court records show that the Peoria doctor pleaded guilty to defrauding multiple insurance companies, including Blue Cross Blue Shield of Arizona, by falsely billing Medicare claims. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 15, 2024 Category: Biotechnology Authors: Greg Barr Source Type: news
CEO named for new West County rehab hospital
A chief executive has been named for a new rehab hospital that is slated to open next month. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 15, 2024 Category: Biotechnology Authors: Diana Barr Source Type: news
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs
Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses. (Source: NYT Health)
Source: NYT Health - April 15, 2024 Category: Consumer Health News Authors: Christina Jewett Tags: United States International Relations Drugs (Pharmaceuticals) Factories and Manufacturing United States Politics and Government Biotechnology and Bioengineering Cystic Fibrosis Cancer Supply Chain Intellectual Property Shortages Govern Source Type: news
